Back to results
US 2009/0155814 A1Published application
Proteins in type 2 diabetes
AssigneePride Proteomics A/S
InventorsKurt HOJLUND, Stephen J. Fey, Peter Mose Larsen, Henning Beck-Neilsen, Krzysztof Wrzesinski
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of naturally occurring compounds and derivatives thereof as markers for predisposition of diabetes related diseases. The invention also relates to a pharmaceutical composition for treatment of diabetes related diseases.
Claims7
A test kit for diagnosing a diabetes-related disease or a predisposition, e.g. genetic, for said disease in a mammal, said test kit comprising:
- (A) at least one binding means which specifically binds to at least one marker protein chosen from the group consisting of:
- (a) ATP synthase beta subunit or phosphorylated ATP synthase beta subunit isoforms;
- (b) phosphoglucomutase 1;
- (c) heat shock protein 90 beta;
- (d) creatine kinase B subunit;
- (e) myosin regulatory light chain 2;
- (f) collagen alpha1 (VI) chain;
- (g) 78 kDa glucose-regulated protein;
- (h) a marker protein defined by the characteristics disclosed in table 3 (match nos:
- 199, 303, 391, or 511);
- (B) at least one means for detecting binding, if any, or the level of binding, of a binding means to at least one of said marker proteins;
- and, if necessary,
- (C) at least one means for correlating whether binding, if any, or the level of binding, to said binding means is indicative of the individual mammal having a significantly higher likelihood of having the disease or a (genetic) predisposition for having the disease.
10 more elements
Dependencies are inferred from the claim text.